Phosphodiesterase 3B is localized in caveolae and smooth ER in mouse hepatocytes and is important in the regulation of glucose and lipid metabolism.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • Publication Information:
      Original Publication: San Francisco, CA : Public Library of Science
    • Subject Terms:
      Lipid Metabolism*; Caveolae/*enzymology ; Cyclic Nucleotide Phosphodiesterases, Type 3/*metabolism ; Endoplasmic Reticulum, Smooth/*enzymology ; Glucose/*metabolism ; Hepatocytes/*metabolism; Animals ; Cholesterol/metabolism ; Cyclic Nucleotide Phosphodiesterases, Type 3/analysis ; Hepatocytes/enzymology ; Metabolic Networks and Pathways ; Mice ; Triglycerides/metabolism
    • Abstract:
      Cyclic nucleotide phosphodiesterases (PDEs) are important regulators of signal transduction processes mediated by cAMP and cGMP. One PDE family member, PDE3B, plays an important role in the regulation of a variety of metabolic processes such as lipolysis and insulin secretion. In this study, the cellular localization and the role of PDE3B in the regulation of triglyceride, cholesterol and glucose metabolism in hepatocytes were investigated. PDE3B was identified in caveolae, specific regions in the plasma membrane, and smooth endoplasmic reticulum. In caveolin-1 knock out mice, which lack caveolae, the amount of PDE3B protein and activity were reduced indicating a role of caveolin-1/caveolae in the stabilization of enzyme protein. Hepatocytes from PDE3B knock out mice displayed increased glucose, triglyceride and cholesterol levels, which was associated with increased expression of gluconeogenic and lipogenic genes/enzymes including, phosphoenolpyruvate carboxykinase, peroxisome proliferator-activated receptor gamma, sterol regulatory element-binding protein 1c and hydroxyl-3-methylglutaryl coenzyme A reductase. In conclusion, hepatocyte PDE3B is localized in caveolae and smooth endoplasmic reticulum and plays important roles in the regulation of glucose, triglyceride and cholesterol metabolism. Dysregulation of PDE3B could have a role in the development of fatty liver, a condition highly relevant in the context of type 2 diabetes.
    • References:
      J Biol Chem. 2002 Mar 8;277(10):8635-47. (PMID: 11739396)
      Annu Rev Biochem. 2007;76:481-511. (PMID: 17376027)
      Methods Enzymol. 1974;31:6-41. (PMID: 4138239)
      Hepatology. 2007 Sep;46(3):813-22. (PMID: 17654701)
      J Cell Biol. 1985 Jul;101(1):201-6. (PMID: 4008528)
      Endocrinology. 1998 Jun;139(6):2699-709. (PMID: 9607775)
      J Biol Chem. 2000 Apr 14;275(15):11348-54. (PMID: 10753948)
      J Biol Chem. 1995 Jun 23;270(25):15231-6. (PMID: 7797507)
      Biochem J. 2005 Nov 15;392(Pt 1):163-72. (PMID: 16153182)
      Biochim Biophys Acta. 2007 Apr;1773(4):584-92. (PMID: 17320989)
      J Biol Chem. 2004 Apr 9;279(15):15214-22. (PMID: 14736883)
      J Biol Chem. 1996 Apr 19;271(16):9690-7. (PMID: 8621645)
      Cell Signal. 2006 Oct;18(10):1713-21. (PMID: 16503395)
      Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):27-38. (PMID: 17690317)
      Trends Endocrinol Metab. 2008 Mar;19(2):65-73. (PMID: 18291668)
      Cell Tissue Res. 2005 Mar;319(3):423-8. (PMID: 15668796)
      Am J Physiol Endocrinol Metab. 2003 Dec;285(6):E1151-60. (PMID: 14607781)
      J Clin Invest. 2006 Dec;116(12):3240-51. (PMID: 17143332)
      J Biochem. 2004 May;135(5):631-7. (PMID: 15173202)
      Diabetes. 1979 Jul;28(7):664-79. (PMID: 221299)
      J Lipid Res. 2005 Jul;46(7):1426-32. (PMID: 15834130)
      Dig Dis Sci. 1982 Aug;27(8):692-700. (PMID: 7047109)
      Eur J Biochem. 2004 May;271(10):2028-36. (PMID: 15128312)
      Biochem J. 2001 Jan 1;353(Pt 1):41-50. (PMID: 11115397)
      Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10104-8. (PMID: 7479734)
      Curr Protoc Cell Biol. 2001 May;Chapter 3:Unit 3.2. (PMID: 18228354)
      Hepatology. 2001 May;33(5):1259-69. (PMID: 11343255)
      Regul Pept. 1986 Feb;13(3-4):283-91. (PMID: 3754646)
      Curr Top Med Chem. 2007;7(4):421-36. (PMID: 17305583)
      Mol Cell Biochem. 2003 Oct;252(1-2):205-11. (PMID: 14577594)
      Biochem J. 2007 Jun 1;404(2):257-68. (PMID: 17324123)
      Cell Cycle. 2007 Jan 15;6(2):115-6. (PMID: 17314510)
      Biochem J. 1987 Feb 15;242(1):33-42. (PMID: 3036087)
      Science. 2006 Sep 15;313(5793):1628-32. (PMID: 16973879)
      Diabetes Care. 2008 Jan;31(1):165-9. (PMID: 17934148)
    • Accession Number:
      0 (Triglycerides)
      97C5T2UQ7J (Cholesterol)
      EC 3.1.4.17 (Cyclic Nucleotide Phosphodiesterases, Type 3)
      IY9XDZ35W2 (Glucose)
    • Publication Date:
      Date Created: 20090306 Date Completed: 20090618 Latest Revision: 20211020
    • Publication Date:
      20240829
    • Accession Number:
      PMC2650791
    • Accession Number:
      10.1371/journal.pone.0004671
    • Accession Number:
      19262749